What's Happening: NAD+ restoration begins affecting mitochondrial function
In the past, GLP-1 agonists were used to treat Type 2 diabetes, such as Semaglutide GLP-1
The potential benefits of weight loss are substantial, improving overall health and well-being
GLP-1 receptor agonists are medications originally developed to help manage type 2 diabetes but are now widely used for weight management and metabolic health
The tirzepatide revolution has begun, and its implications extend far beyond a single medication
Clinical signs may include: Sudden shortness of breath or dyspnea Chest pain that worsens with inspiration Tachycardia and palpitations Lightheadedness, syncope, or hypoxemia in severe cases Nursing assessment should prioritize early detection, as PE can rapidly become fatal if untreated